Prakt. lékáren. 2015; 11(1): 16-18

Inhalation devices for therapy patients with chronic obstruction of airways in the Czech market

Eva Kašáková, Viktor Kašák
Oddělení respiračních nemocí, LERYMED spol. s r. o., Praha

The inhaled route is the first line administration method in the management of asthma, chronic obstructive pulmonary disease (COPD) and

overlap asthma and COPD syndrome (ACOS). Inhaled administration drugs directly into the airways, produced higher local concentrations

with significantly less risk of systemic side effects and rapid onset reliever medication, then oral route. Inhaled medications are available in

different devices with differ characteristics and with differ inhaler technique. Therefore continuing education of patient is very important,

training and skill in correct inhalation technique and inhalation technique must be repeatedly checked. On the education of the patients

should be participated prescribing doctor, specialized nurse and also pharmacist, which drugs and inhalation devices dispensing.

Keywords: inhalation therapy, inhalation devices, correct inhalation technique

Published: February 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kašáková E, Kašák V. Inhalation devices for therapy patients with chronic obstruction of airways in the Czech market. Pharmacy for Practice. 2015;11(1):16-18.
Download citation

References

  1. Global strategy for asthma management and prevention. Revised 2014. GINA 2014. Dostupné na www.ginasthma.org.
  2. Global strategy for asthma management and prevention. Revised 2014. Online appendix. GINA 2014. Dostupné na www.ginasthma.org.
  3. Global strategy for diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD Report, Revised 2014. Dostupné na: www.goldcopd.org.
  4. Kašák V. Inhalační systémy v terapii astmatu. Remedia 2014; 24: 315-320.
  5. Kašák V. Asthma bronchiale, 2. vydání. Maxdorf 2013; 261 s.
  6. Kašáková E. Inhalační systémy. Pomocník alergologa a klinického imunologa. Geum 2014; 253-255.
  7. Kašák V, Feketeová E. Vliv nesprávné inhalační techniky na úroveň kontroly nad astmatem. Alergie 2010; 12: 244-257.
  8. Laube BL, Janssens HM, de Jongh FHC, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J 2011; 347: 1308-1331. Go to original source... Go to PubMed...
  9. Price D, Bosnic-Anticevich S, Briggs A, et al. Inhaler competence in asthma: Common errors, barriers to use and recommended solutions. Resp Med 2013; 107: 37-46. Go to original source... Go to PubMed...
  10. Kašák V, Feketeová E, Macháčková M, Blažková M. Chybovost v užívání inhalačních systémů v léčbě perzistujícího astmatu. Alergie; 2008; 10(Suppl 1): 31-44.
  11. Špičák V, Kašák V, Kašáková E. Jak udržet své astma pod kontrolou? ČIPA, Maxdorf 2014; 48 s.
  12. Bousquet J, Winchester C, Papil A, et al. Inhaled corticosteroid/long-acting ?2-agonist combination therapy for asthma: attitudes of specialists in Europe. Int Arch Allergy Immunol 2012; 157: 303-310. Go to original source... Go to PubMed...
  13. Ninane V, Brussele GG, Luis R, et al. Usage of inhalation device in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement. Exp Opin Drug Deliv 2014; 11: DOI: 10.1517/17425247. Go to original source... Go to PubMed...
  14. Suchopár J. Originály, generika a generická substituce. Alergie 2014; 16: 81-85.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.